NCT05936632View on ClinicalTrials.gov

Preferences for Certainty Versus Access When Evaluating New Cancer Drugs. A Discrete Choice Experiment.

CompletedOBSERVATIONAL

Enrollment

998

Participants

Timeline

Start Date

July 7, 2023

Primary Completion Date

July 20, 2023

Study Completion Date

July 20, 2023

Conditions

Cancer

Interventions

OTHER

Discrete Choice Experiment (DCE)

DCE survey experiment

Trial Locations (1)

WC2A 2AE

London School of Economics, London

All Listed Sponsors

lead

London School of Economics and Political Science

OTHER

NCT05936632 - Preferences for Certainty Versus Access When Evaluating New Cancer Drugs. A Discrete Choice Experiment. | Biotech Hunter | Biotech Hunter